UK markets closed

Biogen Inc (IDP.HM)

Hamburg - Hamburg Delayed price. Currency in EUR
Add to watchlist
203.20+2.80 (+1.40%)
As of 08:00AM CET. Market open.
Full screen
Previous close200.40
Bid203.20 x 0
Ask203.80 x 0
Day's range203.20 - 203.20
52-week range200.40 - 304.00
Avg. volume5
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
Earnings date23 Apr 2024 - 29 Apr 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Zacks

    Here's Why Biogen Inc. (BIIB) Fell More Than Broader Market

    Biogen Inc. (BIIB) concluded the recent trading session at $221.74, signifying a -0.98% move from its prior day's close.

  • Insider Monkey

    14 Best Beaten Down Stocks To Buy Right Now

    In this piece, we will take a look at the 14 best beaten down stocks to buy right now. If you want to skip our coverage of the latest events in the stock market, then you can take a look at the 5 Best Beaten Down Stocks To Buy Right Now. The stock market of […]

  • GlobeNewswire

    Biogen’s QALSODY® (tofersen), the First Therapy to Treat Rare, Genetic Form of ALS, Received Positive Opinion from CHMP

    SOD1-ALS is a devastating, uniformly fatal, and ultra-rare genetic form of ALS affecting less than 1,000 people in Europe1With QALSODY, Biogen has advanced the role of neurofilament in the development of new medicines for ALS, with the potential to accelerate further discovery in the field CAMBRIDGE, Mass., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opin